Share Name Share Symbol Market Type Share ISIN Share Description
Eden Research Plc LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 7.75 7.50 8.00 7.75 7.75 7.75 0.00 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 2.8 -0.5 -0.2 - 16

Eden Research Share Discussion Threads

Showing 7176 to 7198 of 8250 messages
Chat Pages: Latest  294  293  292  291  290  289  288  287  286  285  284  283  Older
DateSubjectAuthorDiscuss
31/5/2019
09:50
Well Sean knows Pam Marrone, so I'm sure he knows the competitive relevance from Marrone bio. I didn't know she had successfully started and exited a business via Bayer "After Monsanto, Marrone founded AgraQuest, a company offering natural products for pest management, which was acquired by Bayer CropScience in July 2012 for $450 million." As for other technology, it is incumbent upon Eden to not only differentiate at the point of sale/licence, but also to educate, inform and differentiate to the investment community so they understand the tech that drives Eden product and will drive others and therefore why Eden is worthy of their investment pounds. This is a fundamental practice that Eden needs to engage in.
investingisatrickygame
31/5/2019
08:25
The long awaited UK approval of Mevalone will be an interesting opportunity for Eden as they have links with many Vineyards/ Big Wine makers like Chapel Down who have been part of the Trials process. I'm hoping for a Fitbug type 'association' moment where people maybe motivated to invest because Mevalone becomes tangible to them and part of something they can relate too... Wine. Being a Uk product/company might also appeal to those with a Red Tractor mentality approach to Eating and Drinking as well . hTTps://blogs.lse.ac.uk/businessreview/2019/05/30/uk-wine-the-risks-and-opportunities-of-a-changing-climate/ hTTps://www.investegate.co.uk/chapel-down-group-plc--cdgp-/bus/final-results/20190530070000Z9521/
supersonico
31/5/2019
06:20
A very relevant read follows, and readers will also note a reference and link to another story regarding a competing encapsulation technology, which in my view does not as have the same level of attributes that Sustaine has - For Biologics to Succeed, ‘Plug & Play’ Inputs Must Give Way to Holistic Farm Management MAY 30, 2019 LAUREN MANNING As lawmakers, court battles, and consumer demand continue to push conventional chemical inputs out of the picture, a major market opportunity for bio-based inputs has developed. However, many farmers are struggling to understand an entirely new production methodology, argues biologicals veteran Pam Marrone. Biologicals consist of natural crop protection and plant health solutions that can be used alone or as part of a program that incorporates conventional pesticides and fertilizers. Looking specifically at crop protection, biopesticides are capturing an increasing share of the pesticide market, according to research group Research & Markets. Pam Marrone, CEO and founder of Marrone Bio Innovations, one of the first high profile biopesticide groups, says biologicals are the fastest-growing segment in pesticides globally. However, there is still a lack of awareness or understanding among farmers in how to incorporate their use into their operations, she tells AgFunderNews. Full story - hTTps://agfundernews.com/for-biologics-to-succeed-plug-play-inputs-must-give-way-to-holistic-farm-management.html
wan
30/5/2019
14:54
If only TT could agree on the colour of the Lid ..news Sustainable approach to Poultry Red Mite explored Scientists are hoping to develop sustainable approaches to control Poultry Red Mite (PRM) in commercial laying hen systems. The MiteControl project, which is due to run until April 2022, aims to develop effective and sustainable non-chemical treatment methods to control PRM using an Integrated Pest Management (IPM) approach. Economic loss PRM pose a substantial threat to global egg production, and is particularly prevalent in North West Europe, with more than 90% of farmers likely to be affected by the parasite, accounting for an estimate loss of €360m annually. hTTps://www.poultryworld.net/Health/Articles/2019/5/Sustainable-approach-to-Poultry-Red-Mite-explored-430994E/?utm_source=Sociallymap&utm_medium=Sociallymap&utm_campaign=Sociallymap
supersonico
30/5/2019
14:50
Since you are all sparking off. I really think you have not referred to the right member of the BOD.I alluded to him Quite a long time ago.I was very deadpan as to where the share price would go.Its his baby and he wants to nurture it and probably see it past its teens , while being the controlling head of the household. I now believe the company is very much in danger of losing out during its slow steady growth phase.Innovation of its big competitors is happening,the regulatory rules are fast changing and this is precisely the time that Eden should be dancing up and down They are very much in danger of losing out to competitors by not promoting themselves .Its almost as if there is a shareholder stitch up in the making.That is my worst fear
chrischas
30/5/2019
14:16
Ok thanks for the help I'll try Sean
dplewis1
30/5/2019
14:00
I've often had prompt responses from Sean Smith.
supersonico
30/5/2019
13:47
Not sure you will get a reply, I wrote a couple of weeks back asking if there was some sort of strategy in place to capitalise on this current anti pesticide press... and no response as yet..
bjlk
30/5/2019
13:37
sean@edenresearch.com
supersonico
30/5/2019
12:59
dplewis1..Two guesses; 1)We are in the Dampening part of the cycle. A purchase by Lykele risks tipping that which would be problematic if a further strategic investor is planned. 2)Lykele is a Bayer linkman and as such holds privileged information which makes him an insider. He expected a short ordered Parallel delay but something kicked those conjoined cans further down the road.
supersonico
30/5/2019
12:47
Regretting my decision to reinvest here.. Does anyone know why this Lykele bloke doesn't own any shares?
dplewis1
30/5/2019
12:20
Investing, a brilliant post..I really think Eden should read, inwardly digest and come up with a strategy to fulfil their complete job descriptions ...Definitely the massive jam tomorrow question but now well past sell by date..Share options expiring doesn't seem to light the fuse either.. I'm at a loss as to what will ignite some urgency with our short order management..
bjlk
30/5/2019
11:34
good spot super
attyg
30/5/2019
11:02
Eden Research plc@edenresearch The 2019 season in Italy closely resembles 2013 - repeated rains and cold temperatures in spring - leading to high risk of fungal diseases such as #botrytis. Preventative spray programmes are essential. hTTps://www.millevigne.it/index.php/news/635-lo-stop-precoce-alla-botrite-passa-dai-terpeni
supersonico
30/5/2019
08:42
I know a number of people are really fed up with the ongoing lack of value being reflected in the share price. I certainly am. How long, even in a regulatory framework, can one continue with the mantra that these things take time, especially when we have two commercial products, delivered via Sustaine, with Sustaine (we assume, not unreasonably) having successful trials elsewhere with Agrochemical majors and full confirmations still to come alongside commercial arrangements. Mevalone is now a global product as a result of Sipcam's uptake right's. It is, we are told, being used now as a pre-harvest, 'protector'/'insurer' against the possible later onset of Botrytis and it has post harvest viability too. Exempt from MRL & Generally Regarded As Safe (GRAS), Mevalone is the Natural Solution. From a marketing perspective, Eden and Powerscourt have everything to hand here except organic status. This story can run well either with the support of the press or stand alone using video and distribution partners to place in the right channels for understanding and word-of-mouth. Many people should be talking about Eden to the positive and it should create its own direction of travel. This is before we even address Cedroz which has a bigger impact, plus the awaited new products in bigger markets. You can take a definition from wherever you want, I've taken the easiest to find. "The chief executive officer (CEO)[1] or just chief executive (CE), is the most senior corporate, executive, or administrative officer in charge of managing an organization – especially an independent legal entity such as a company or nonprofit institution. CEOs lead a range of organizations, including public and private corporations, non-profit organizations and even some government organizations (e.g., Crown corporations). The CEO of a corporation or company typically reports to the board of directors and is charged with maximizing the value of the entity,[1] which may include maximizing the share price, market share, revenues or another element. In the non-profit and government sector, CEOs typically aim at achieving outcomes related to the organization's mission, such as reducing poverty, increasing literacy, etc. In the early 21st century, top executives typically had technical degrees in science, engineering or law.[2]" From above "The CEO of a corporation or company typically reports to the board of directors and is charged with maximizing the value of the entity,[1] which may include maximizing the share price" I have no issue with Sean's online delivery, nor his connections, nor his IP knowledge and background. I have no basis to, I doubt anyone does. However, he is not maximising the share price. It cannot be argued one day Rodney, when so many days have passed with the result of the above products, relationships and technology. And we have a former high ranking employee of Bayer as our Chairman which doesn't on the face of it after 18 months in situ, appear to be delivering anything of value that we as shareholders can measure. That is fair observation. A CEO has to deliver share price value and that has to be on an ongoing basis, trending upwards and in line with business performance + forward prospects, traditionally measured on a three year timeline. Eden has nothing factored in for the latter and much of its business achievement thus far not factored in to today's share price. It is illogical and unrealistic to expect that one moment in time, yet to come, will catapult the share price north and vertical in an instant and correct all share price performance woes to-date. That if it ever happened, would lead to a mass sell out and a decline in the share price as quick as the incline that occurred. The CEO of Eden has to maximise the share price now and this is an ongoing role and responsibility. it isn't to be implemented when you wish to. It is an ongoing process. NDA's, partners et al do not have the power to supress another's share price and it is unthinkable to imagine this can be so. I know the BoD will read this and other posts and I know they will know who wrote this. I have no ill will towards the BoD, but our CEO whoever that may be an any point in time has to do their utmost to ensure that the share price of today and every day reflects the true value of the Company today. If they truly believe our share price and market cap is fair value right now, then do nothing at circa £23 million. If however this is not what they believe and know value to be, then they need to act to move the share price and show their audience true reasons why the share price should be much higher and therefore why people should invest in it today. This 'moan' by many is not going to go away until it is dealt with. Institutions are not and do not buy into Eden at this level. So they truly have no options but to stir up the market and in due course the hoped for institutions might come on board. Is our current CEO going to be the CEO to put value into the share price today based on current achievements or is another going to be brought into the business to deliver that value today, as well as the ongoing process of creating value for the future, the latter of which I am sure Sean is seeking to achieve.
investingisatrickygame
29/5/2019
13:09
Again, no more 5 a day then. Too dangerous!
investingisatrickygame
29/5/2019
12:02
Looking forward to reading the Farage / Banks /Trump.. Kill em All.. Food and Farming Manifesto. Pesticides explained: the toxic chemicals in up to 70% of produce Studies have linked long-term health issues, while regulators insist breaches of safe limits are rare hTTps://www.theguardian.com/us-news/2019/may/29/pesticides-everyday-products-toxics-guide …………. hTTps://www.ewg.org/news-and-analysis/2019/05/court-docs-monsanto-paid-chemical-industry-front-group-claim-cancer ..//////// BASF collaborates with Rothamsted Research on sustainable agriculture...…….. rather than kill us all ag.. that's nice of them.. hTTps://www.basf.com/global/en/media/news-releases/2019/05/p-19-224.html
supersonico
29/5/2019
09:14
I should have mentioned that my thrust was aimed at Eden's development of post harvest applications.
wan
29/5/2019
08:58
Very interesting research and worrying findings regarding a current fungicide used in post harvest application. The technique developed can be used to detect and assess the penetration of fungicides into fruits and vegetables. Research conducted at the Federal University of Goiás (UFG), in partnership with Louisiana State University, has shown that the imazalil fungicide-type pesticide, apparently one of the most used in post harvest application of fruits and vegetables, penetrates beyond the outer skins in only a matter of days - University creates technique that identifies use of agrochemicals in fruits Privacy Policy 25/05/19 "We found that the substance penetrates beyond the fruit peel, reaching in a short time its internal structures, which can harm the health of the consumer, even if the peel is washed," "Unlike what is said in the specifications of the fungicide, its molecule is not degraded by light and, as a result, it ends up penetrating the fruit," he added, referring specifically to imazalil, used to inhibit fungal growth, postponing rot of product. "Although Brazil does not make use of this fungicide, the technique developed allows us to develop methods on the application of other pesticides, fungicides or agrochemicals in other hortifrutis. In fact, we are already working with tomatoes in a similar approach, "he added. Full story (requires translating) - hTTps://istoe.com.br/universidade-cria-tecnica-que-identifica-uso-de-agrotoxicos-em-frutas/ So, beyond the benefits and sustainability of reducing food waste post harvest, this is also an application that will come under increasing regulatory scrutiny and indeed consumer preference!
wan
28/5/2019
09:25
Eden Research plc@edenresearch Eden Research plc Retweeted NematodeFacts #Cedroz is an innovative new nematicide which targets root knot #nematodes. Eden's encapsulation technology enables #terpenes to be used as an effective, sustainable solution and a valuable part of #IPM. hTTps://twitter.com/NematodeFacts/status/1129552200987041795
supersonico
27/5/2019
12:04
The Green parties had significant/positive results in European elections. Interesting times...
sortudo7
27/5/2019
05:34
Brucie...I would also add the following excerpt from post 420 - I believe the strength of Eden's intellectual property portfolio is already evident in terms of their existing partners involvement and investments, not to mention that those partners have their own 'extensive' patent portfolio's and expertise. Regulatory approvals will further cement that strength and further strengthen Eden's negotiating hand, not to mention strengthen the share price, hence we need to maintain our patience. (END) Followed by an excerpt from the Chairman's AR Statement; "There is potential for an even greater opportunity around the use of Eden’s proprietary, natural micro-encapsulation technology, Sustaine™, which is being tested by a number of third parties, including some of the major agchem companies." Put another way, the products work and there is no effective workaround from a patent perspective. So, there would appear to be 'significant' value locked up in Eden's patent portfolio. So, whilst sales are obviously an important aspect, and the regulatory backdrop another, the patent portfolio is a key enabler, hence the partners commitment and investment to date and indeed the increased interest from third parties in Sustaine. Given the trajectory of product authorisations (and sales) and label extensions, not to mention the advanced pipeline, my guess is that this is also serving to focus the minds of those interested in Sustaine! Again, put another way, with Sustaine's accelerating validation (a very important and overlooked aspect), third parties will almost certainly have to pay handsomely (in one form or another!) to get access to Sustaine. Food for thought; Given the accelerating evidence and validation of Sustaine and indeed the increased interest in Sustaine from third parties, Bayer's 'years' of delay in commercialisation of AH products, is perhaps better put into perspective! Btw, I have not had access to or had any details regarding the Shore Report.
wan
26/5/2019
18:35
All great points, Wan. Yes, indeed, along with rising revenues (hopefully/needfully doubling yoy) we have the current mcap of £21m set against the cost of bring biopesticides to market. Plus interest of Sipcam, Eastman (+Sumi, Bayer etc.) And then the 'addressable market size' today and tomorrow on a CAGR of 17% . With Sustaine as the Great Unknown It's just gonna take some time to come together. Have you had a chance to consider the recent Shore report, either directly or by hearsay?
brucie5
Chat Pages: Latest  294  293  292  291  290  289  288  287  286  285  284  283  Older
Your Recent History
LSE
EDEN
Eden Resea..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191115 02:36:47